Concourse Financial Group Securities’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-200
| Closed | -$8.84K | – | 1714 |
|
|
2024
Q4 | $8.84K | Hold |
200
| – | – | ﹤0.01% | 1745 |
|
|
2024
Q3 | $9.4K | Sell |
200
-69
| -26% | -$3.24K | ﹤0.01% | 1706 |
|
|
2024
Q2 | $14.5K | Buy |
269
+66
| +33% | +$3.56K | ﹤0.01% | 1591 |
|
|
2024
Q1 | $13.8K | Buy |
203
+1
| +0.5% | +$68 | ﹤0.01% | 1608 |
|
|
2023
Q4 | $12.6K | Hold |
202
| – | – | ﹤0.01% | 1620 |
|
|
2023
Q3 | $9.17K | Buy |
202
+2
| +1% | +$91 | ﹤0.01% | 1672 |
|
|
2023
Q2 | $11.2K | Hold |
200
| – | – | ﹤0.01% | 1615 |
|
|
2023
Q1 | $9.05K | Hold |
200
| – | – | ﹤0.01% | 1690 |
|
|
2022
Q4 | $8.13K | Buy |
+200
| New | +$8.13K | ﹤0.01% | 1723 |
|
|
2022
Q3 | – | Sell |
-200
| Closed | -$12K | – | 3159 |
|
|
2022
Q2 | $12K | Hold |
200
| – | – | ﹤0.01% | 1597 |
|
|
2022
Q1 | $13K | Sell |
200
-225
| -53% | -$14.6K | ﹤0.01% | 1605 |
|
|
2021
Q4 | $32K | Sell |
425
-76
| -15% | -$5.72K | ﹤0.01% | 1461 |
|
|
2021
Q3 | $56K | Sell |
501
-39
| -7% | -$4.36K | ﹤0.01% | 1256 |
|
|
2021
Q2 | $87K | Buy |
540
+62
| +13% | +$9.99K | 0.01% | 1046 |
|
|
2021
Q1 | $58K | Buy |
478
+232
| +94% | +$28.2K | ﹤0.01% | 1164 |
|
|
2020
Q4 | $38K | Buy |
246
+63
| +34% | +$9.73K | ﹤0.01% | 1230 |
|
|
2020
Q3 | $15K | Sell |
183
-57
| -24% | -$4.67K | ﹤0.01% | 1437 |
|
|
2020
Q2 | $18K | Buy |
240
+140
| +140% | +$10.5K | ﹤0.01% | 1319 |
|
|
2020
Q1 | $4K | Hold |
100
| – | – | ﹤0.01% | 1699 |
|
|
2019
Q4 | $6K | Buy |
+100
| New | +$6K | ﹤0.01% | 1565 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2553 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2925 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2901 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2776 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2334 |
|